Related references
Note: Only part of the references are listed.Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders
Elia Sechi et al.
NEUROLOGY (2021)
MRI differences between MOG antibody disease and AQP4 NMOSD
Sara Salama et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder
Min Young Lee et al.
NEUROLOGY (2020)
EU paediatric MOG consortium consensus: Part 1-Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
Arlette L. Bruijstens et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2020)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Maciej Jurynczyk et al.
BRAIN (2017)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
Dalia L. Rotstein et al.
JAMA NEUROLOGY (2015)
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Patrick Waters et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
Joanna Kitley et al.
JAMA NEUROLOGY (2014)
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
Joanna Kitley et al.
BRAIN (2012)
Serologic diagnosis of NMO A multicenter comparison of aquaporin-4-IgG assays
P. J. Waters et al.
NEUROLOGY (2012)